Actualités Sernova Corp - SVA | Actions TSX Venture Exchange

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

NEW YORK, March 29, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the...

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

LONDON, Ontario, March 22, 2021 (GLOBE NEWSWIRE) -- Sernova Corp. (OTCQB:SEOVF)(TSX-V:SVA)(FSE/XETRA:PSH), a...

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

NEW YORK , March 19, 2021 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its...

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

BAYSTREET -- June 18, 2020 -- InvestorsHub NewsWire -- via Glenn Wilkins -- It’s probably the farthest from the minds...

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in its Phase I/II Clinical Trial for Type-1...

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study for Diabetes LONDON...

Sernova Completes Oversubscribed Private Placement of $2,754,000

LONDON, Ontario, July 23, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for DiabetesLondon, ON -- July 5, 2018 -- InvestorsHub NewsWire...

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

LONDON, Ontario, July 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SVA...

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

LONDON, Ontario, May 14, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

LONDON, Ontario, May 08, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

LONDON, Ontario, May 04, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH...

Sernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM Systems

Continuous Glucose Monitoring System (CGM) to provide sensitive tracking of key efficacy measures in patients at important time points...

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Gluco...

LONDON, Ontario, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Sernova Corp. (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a...

Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference

LONDON, Ontario, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Sernova Corp (TSX-V:SVA) (OTCQB:SEOVF) (FSE:PSH), a...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Sernova Corp (SVA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SVA Actualités

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Completes Oversubscribed Private Placement of $2,754,000

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

Sernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM Systems

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Gluco...

Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Sernova Corp (SVA) Actualités

Sernova Corp (SVA)

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

SVA Actualités

Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing

Sernova to Webcast Live at Life Sciences Investor Forum March 25th

Virtual Conference for Life Sciences Companies Broadcast Live March 25th, 2021

PURA SVA - Health Stocks Exhibit Healthy News, Robust Share Hikes

Sernova Confirms Enduring Levels of Fasting C-Peptide in Bloodstream of First Patient in Phase I/II Clinical Trial for Type-A

Sernova Announces First Transplantation of Therapeutic Cells in Cell Pouch for the Company's Phase I/II U.S. Clinical Study

Sernova Completes Oversubscribed Private Placement of $2,754,000

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Initiates Patient Screening and Recruitment for its US Clinical Trial for Diabetes

Sernova Announces University of Chicago Institutional Review Board (IRB) Approval of the FDA-cleared Therapeutic Cell Pouch C...

Sernova Announces U.S. Phase I/II Cell Pouch Clinical Trial with Prominent Diabetes Clinical Investigator

Sernova Announces Results of 2018 Annual General Meeting of Shareholders and New Chief Financial Officer

Sernova's Cell Pouch Regenerative Medicine Clinical Trial for Type 1 Diabetes Supported with CGM Systems

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Gluco...

Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application